Загрузка...
Ticagrelor-induced thrombotic thrombocytopenic purpura: A case report and review of the literature
RATIONALE: Ticagrelor, a new type of P2Y(12) receptor antagonist, has been highly recommended to be used in acute coronary syndrome by the latest guideline, but its side effects are not well-known. We seek to illustrate a potential fatal condition, thrombotic thrombocytopenic purpura (TTP), caused b...
Сохранить в:
| Опубликовано в: : | Medicine (Baltimore) |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Wolters Kluwer Health
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6039671/ https://ncbi.nlm.nih.gov/pubmed/29952973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011206 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|